11085 Torreyana Road
San Diego, CA 92121
January 13, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Arzhang Navai, Office of Life Sciences |
| Re: | BioAtla, Inc. Registration Statement on Form S-3 Filed January 6, 2023 File No. 333-269148 REQUEST FOR ACCELERATION OF EFFECTIVENESS |
Acceleration Request
| Requested Date: | January 17, 2023 | |
| Requested Time: | 4:00 p.m. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-269148) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540.
[Signature page follows]
| Sincerely, | ||
| BIOATLA, INC. | ||
| By: | /s/ Richard Waldron | |
| Name: Richard Waldron | ||
| Title: Chief Financial Officer | ||
| cc: | Chris Vasquez, BioAtla, Inc. |
Niki Fang, Esq., Orrick, Herrington & Sutcliffe LLP